Viewing Study NCT05964361


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-02-25 @ 5:49 PM
Study NCT ID: NCT05964361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-25
First Post: 2023-07-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
Sponsor: University Hospital, Antwerp
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module